Skip to main content

New Directions for the Design of Parathyroid Hormone Antagonists

  • Chapter
  • 89 Accesses

Abstract

Peptide hormone antagonists that are effective in vivo are uniquely precise tools for biomedical research. They can be used to determine how peptide hormones act, what their role is in normal physiological processes, and how they contribute to pathophysiologic states.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. M. Rosenblatt, Peptide hormone antagonists that are effective in vivo:lessons from parathyroid hormone, N. Engl. J. Med. 315:1004 (1986).

    Article  PubMed  CAS  Google Scholar 

  2. N. Horiuchi, M. P. Caulfield, J. E. Fisher, M. E. Goldman, R. L. McKee, J. E. Reagan, J. J. Levy, R. F. Nutt, S. B. Rodan, T. L. Schofield, T. L. Clemens, M. Rosenblatt, Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro. Science 238:1566 (1987).

    Article  PubMed  CAS  Google Scholar 

  3. S. H. Doppelt, R. M Neer, S. R. Nussbaum, P. Federico, J. T. Potts, Jr., M. Rosenblatt, Inhibition of the in vivo parathyroid hormone-mediated calcemia response in rats by a synthetic hormone antagonist, Proc. Natl. Acad. Sci. USA 83:7557 (1986).

    Article  PubMed  CAS  Google Scholar 

  4. N. Horiuchi, M. F. Holick, J. T. Potts, Jr., M. Rosenblatt, A parathyroid hormone inhibitor in vivo:design and biological evaluation of a hormone analog, Science 220:1053 (1983).

    Article  PubMed  CAS  Google Scholar 

  5. N. Horiuchi, M. Rosenblatt, Evaluation of a parathyroid hormone antagonist in an in vivo multiparameter bioassay, Am. J. Phy s. 253:E187 (1987).

    CAS  Google Scholar 

  6. S. R. Nussbaum, N. V. Bendetti, G. D. Fasman, J. T. Potts, Jr., M. Rosenblatt, Design of analogues of parathyroid hormone:a conformational approach, J. Prot. Chem. 4:391 (1985).

    Article  CAS  Google Scholar 

  7. A. Bundi, R. Andreatta, W. Rittel, K. Wuthrich, Conformational studies of the synthetic fragment 1–34 of human parathyroid hormone by NMR techniques, FEBS Lett. 64:126 (1976).

    Article  PubMed  CAS  Google Scholar 

  8. L. M. Smith, J. Jentoft, J. E. Zull, Proton NMR studies of the biologically active 1–34 fragment of bovine parathyroid hormone:examination of a structural model, Arch. Biochem. Biophys. 253:81 (1987).

    CAS  Google Scholar 

  9. J. E. Zull and N. B. Lev, A theoretical study of the structure of parathyroid hormone, Proc. Natl. Acad. Sci. USA 77:3791 (1980).

    Article  PubMed  CAS  Google Scholar 

  10. A. Bundi, R. H. Andreatta, K. Wuthrich, Characterization of a local structure in the synthetic parathyroid hormone fragment 1–34 by XH nuclear-magnetic-resonance techniques, Eur. J. Biochem. 91:201 (1978).

    Article  PubMed  CAS  Google Scholar 

  11. D. M. Barnes, New tumor factor may disrupt calcium levels, Science 237:363 (1987).

    Article  PubMed  CAS  Google Scholar 

  12. L, J. Suva, G. A. Winslow, R. E. H. Wettenhall, R. G. Hammonds, J. M. Moseley, H. Diefenbach-Jagger, C. P. Rodda, B. E. Kemp, H. Rodriguez, E. Y. Chen, P. J. Hudson, T. J. Martin, W. I. Wood, A parathyroid-hormone-related protein implicated in malignant hypercalcemia:cloning and expression, Science 237:893 (1987).

    Article  Google Scholar 

  13. R. A. Nissenson, S. Leung, D. Diep, R. D. Williams, G. J. Strewler, Purification of a low molecular weight form of the tumor-derived parathyroid hormone-like protein, J. Bone & Mineral Research 2:Abstract 388 (1987).

    Google Scholar 

  14. A. F. Stewart, T. Wu, D. Goumas, W. J. Burtis, Amino-terminal sequence of a human HHM-associated adenylate cyclase-stimulating protein contains PTH-like and PTH-unlike domains, J. Bone & Mineral Research 2:Abstract 392 (1987).

    Google Scholar 

  15. S. B. Rodan, K. L. Insogna, A. M-C Vignery, A. F. Stewart, A. E. Broadus, S. M. D’Souza, D. R. Bertolino, G. R. Mundy, and G. A. Rodan, Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells, J. Clin. Invest. 72:1511 (1983).

    Article  PubMed  CAS  Google Scholar 

  16. R. A Nissenson, G. J. Strewler, R. D. Williams, S. C. Leung, Activation of the parathyroid hormone receptor-adenylate cyclase system in osteosarcoma cells by a human renal carcinoma factor, Cancer Res. 45:5358 (1985).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Rosenblatt, M. et al. (1989). New Directions for the Design of Parathyroid Hormone Antagonists. In: Massry, S.G., Fujita, T. (eds) New Actions of Parathyroid Hormone. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0567-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0567-5_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-7870-2

  • Online ISBN: 978-1-4613-0567-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics